Match each clinical infectious disease vignette with its most appropriate targeted pharmacotherapy or first-line treatment regimen.
- A 45-year-old man with poor dentition presents with a chronic, indurated submandibular mass and multiple sinus tracts exuding yellowish purulent discharge. Microscopy of the exudate shows branching, non-acid-fast, Gram-positive bacilli.Prolonged therapy with high-dose penicillin G or amoxicillin
- A 58-year-old renal transplant recipient presents with fever, focal seizures, and a cavitary lung lesion. Sputum microscopy demonstrates filamentous, branching, Gram-positive rods that are weakly acid-fast.High-dose intravenous trimethoprim-sulfamethoxazole
- A 65-year-old man with acute myeloid leukemia develops profound neutropenia and persistent fever despite broad-spectrum antibacterials. Chest CT reveals a dense pulmonary macronodule surrounded by a ground-glass halo.Targeted therapy with intravenous voriconazole
- A 32-year-old man with advanced HIV presents with a 2-week history of insidious headache and lethargy. Cerebrospinal fluid analysis reveals elevated opening pressure and encapsulated yeast organisms on an India ink preparation.Induction therapy with liposomal amphotericin B and flucytosine
- A 72-year-old woman is evaluated for acute-onset altered mental status and fever. Cerebrospinal fluid analysis shows neutrophilic pleocytosis. Gram stain reveals intracellular and extracellular Gram-positive bacilli with tumbling motility.Targeted therapy with intravenous ampicillin
Cevap
Vignette 1 matches with Penicillin G/Amoxicillin, Vignette 2 matches with Trimethoprim-sulfamethoxazole, Vignette 3 matches with Voriconazole, Vignette 4 matches with Amphotericin B and flucytosine, and Vignette 5 matches with Ampicillin.
Each specific pathogen presentation is correctly matched with its guideline-directed targeted antimicrobial therapy based on strict microbiological characteristics (Gram stain, acid-fastness, India ink) and classic clinical syndromes.
Adım Adım Çözüm
Anahtar Kavram
Diagnosis and targeted pharmacotherapy of specific opportunistic and severe infectious diseases